Trial Protocol ID USOR 20363_D8532C00001_SERENA-4

Trial Description

SERENA-4: A Randomised, Multicentre, Double-Blind, Phase III Study of AZD9833 (an Oral SERD) plus Palbociclib versus Anastrozole plus Palbociclib for the Treatment of Patients with Estrogen Receptor

Contact us regarding Clinical Trials at or call us at 877-664-7724


  • Courtney Ackerman, M.D.

Disease Types


  • AstraZeneca NCT ID

  • NCT04711252